Traws Pharma
Price & Volume
Stats
See moreOpen | $1.64 |
Previous Close | $1.61 |
Day Range | $1.63-$1.64 |
52W Range | $0.97-$3.26 |
Market Cap | $11.8M |
Shares Short | 411,637 |
Financials
See moreRevenue (12 Mos) | $2.8M |
Revenue Growth (YoY) | 4,694.7% |
Gross Profit (12 Mos) | $2.8M |
Diluted EPS | -$1.82 |
News
See moreYahoo Finance • 4 months ago
Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients
Yahoo Finance • 6 months ago
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
Yahoo Finance • 6 months ago
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
Yahoo Finance • 7 months ago
Annovis Appoints Mark Guerin as Chief Financial Officer
About
CEO | Dr. Iain D. Dukes DPHIL, M.A., Ph.D. |
Address | 12 Penns Trail, Newtown, PA, United States, 18940 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
